Chargement en cours...
Molecular docking study of P4-Benzoxaborolesubstituted ligands as inhibitors of HCV NS3/4A protease
NS3/4A protease is an important emerging target for the cure of hepatitis C. There are many inhibitors of HCV NS3/4A protease that are passing through the clinical improvement indicating momentous reduction in the viral infection rate of patients. In this study molecular docking via MOE-Dock program...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Biomedical Informatics
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607190/ https://ncbi.nlm.nih.gov/pubmed/23559750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630009309 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|